Register for an account

X

Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.

X

Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.

Health

Gene Therapy Could Prevent Arthritis

D-briefBy Lisa RaffenspergerMarch 13, 2013 10:22 PM

Newsletter

Sign up for our email newsletter for the latest science news

shutterstock_89553295.jpg

Most people who live to old age will suffer from arthritis. The condition's prevalence is growing alongside a graying world population. However the only treatments at the moment address the symptoms rather than the cause---the loss of cartilage in joints. Joint replacement is a last-ditch solution for some sufferers. Now a gene therapy approach has demonstrated promise in staving off arthritis in mice, opening the door to human testing. The inspiration for the research came from studying children with a genetic form of arthritis that strikes early. These children are deficient in the gene for a protein called lubricin. Lubricin is thought to act as a lubricant between the bones in a joint. Since a lack of lubricin caused arthritis, researchers thought perhaps additional lubricin could stave it off. They tested this hypothesis by creating a strain of mice with an additional lubricin gene in their DNA. When these mice suffered an injury to their knees they didn't develop injury-induced arthritis. Inspection of the mice's joints found that their cartilage resembled mice who'd never been injured in the first place. Non-modified mice, on the other hand, had symptoms of arthritis just a month after injury. What's more, as the mice that made extra lubricin aged, their cartilage stayed youthful. That suggests the protein may protect against both common forms of arthritis: injury-related and age-related. The treatment also works if the replacement genes are injected right into the joint itself, the researchers report

in Science Translational Medicine today. Its delivery to human patients, then, could be similar to the injection of joint lubricants

that some arthritis sufferers currently rely on. However no gene therapies are currently approved by the FDA for human treatment, so this research will likely stay in the lab for some time yet. And, importantly, the gene therapy just staves off cartilage loss; it doesn't regenerate lost cartilage. But the treatment could be a promising option for preventing the onset of arthritis in early stages of the disease or after injury. Image courtesy OneSmallSquare / Shutterstock

2 Free Articles Left

Want it all? Get unlimited access when you subscribe.

Subscribe

Already a subscriber? Register or Log In

Want unlimited access?

Subscribe today and save 70%

Subscribe

Already a subscriber? Register or Log In